Pursuing the pattern of President Biden and his coronavirus adviser, Dr . Anthony Fauci, “ fully vaccinated” CDC Director Doctor Rochelle Walensky experienced a “ rebound” of COVID-19 after completing a circular of Pfizer’s antiviral treatment Paxlovid.
The CDC said Mon that Walensky tested good for COVID-19 earlier this month and eventually tested damaging after taking Paxlovid, that is under emergency use authorization. On Sunday, however , the girl “ began to develop mild symptoms and has again tested good. ”
“ Consistent with CDC guidelines, she actually is isolating at home and will take part in her planned meetings virtually, ” the agency mentioned.
Walensky, after receiving four doses of the original Pfizer mRNA COVID-19 vaccine, tested positive for COVID-19 upon Oct. 21, about one month after receiving the new bivalent booster designed to target the omicron versions.
Last Wednesday, President Biden– who was infected with COVID-19 in July after getting four shots and promising the shot would prevent infection – on Tuesday urged all of the Americans to get the new booster, claiming it’s “ incredibly effective. ”
However , a preprint study released Oct. 24 by a prominent Columbia University virologist discovered that the new booster creates fewer antibodies than the unique vaccine.
‘ Risky business’
In May, the CDC issued a official warning that a course of Paxlovid could produce a rebound associated with COVID-19. One month later, Fauci, the director of the Nationwide Institute of Allergy plus Infectious Diseases, said he experienced a rebound of COVID symptoms after he was treated with the drug .
Biden also skilled a Paxlovid rebound right after testing negative. As he has been recovering, the FDA sent a letter on August. 5 to Pfizer asking the company’s protocol for the medication and asking for a study to become completed by September 2023.
When the rebound issue surfaced in the springtime, Pfizer CEO Albert Bourla told Bloomberg that patients should take another course of the treatment, “ like you perform with antibiotics. ” However the FDA’s infectious disease director, Dr . John Farley, reacted, saying there is “ no evidence of benefit at this time to get a longer course of treatment or repeating a treatment course of Paxlovid in patients with recurrent COVID-19 symptoms. ”
Bourla, the Pfizer main, also tested positive designed for COVID-19 after receiving four doses of his carrier’s vaccine. When the shots were rolled out, he promised they would be 100% effective in preventing contamination .
Within July, virology researchers at Austria’s Healthcare University of Innsbruck released an analysis of the Pfizer trial in which they found little distinction in the number of hospitalizations or even deaths between placebo plus Paxlovid recipients.
Further, they found the particular drug could accelerate mutations in SARS-CoV-2, the virus that causes COVID-19. Johns Hopkins medical professor Marty Makary said the study clearly showed that Paxlovid “ excessive use in low-risk people may breed resistance and spawn new virus mutations, ” calling it “ dangerous business. ”
The FDA, nevertheless, has authorized state-licensed pharmacists in order to circumvent doctors by directly prescribing it.
Philadelphia cardiologist Dr . Anish Koka wrote in the newsletter in July that seven a few months after its approval, “ Apparently, someone in govt decided that there wasn’t sufficient Paxlovid being prescribed. ”
The physician stated he has “ struggled along with quite a few Paxlovid requests recently, ” mostly from “ young vaccinated patients. ” The patients, he said, feel pressured to take the therapy, and they “ just really want some reassurance from a expert that it’s OK to not have a drug. ”
Koka said he received a “ panicked call” from an emergency room any time a vaccinated and boosted elderly patient developed fevers plus chills after completing a round of Paxlovid he previously prescribed.
Your doctor now regrets that he had been exposing his patient “ to the adverse events of a drug with little to no benefit, ” whenever “ doing nothing” tend to work better “ the vast majority of time. ”